{"id":"doi:10.1038/nprot.2017.143","kind":"article","title":"CRISPR/Cas9 genome editing in human hematopoietic stem cells","authors":["Rasmus Otkjær Bak","Daniel P. Dever","Matthew Hebden Porteus"],"author_count":3,"year":2018,"published":"2018-01-25","venue":"Nature Protocols","cited_by":319,"doi":"10.1038/nprot.2017.143","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/nprot.2017.143","archive_url":"https://space-kitty.com/papers/doi:10.1038/nprot.2017.143","updated":null,"pmid":"29370156","pmcid":null,"openalex_id":"W2784423079","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["CRISPR and Genetic Engineering"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}